Sangamo Therapeutics, Inc. (FRA:GBY)
0.3025
-0.0010 (-0.33%)
At close: Jan 19, 2026
Revenue by Product
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.